Chemokine CCL7 mediates trigeminal neuropathic pain via CCR2/CCR3-ERK pathway in the trigeminal ganglion of mice

LP Zhu, ML Xu, BT Yuan, LJ Ma, YJ Gao - Molecular Pain, 2023 - journals.sagepub.com
Background Chemokine-mediated neuroinflammation plays an important role in the
pathogenesis of neuropathic pain. The chemokine CC motif ligand 7 (CCL7) and its receptor …

CXCL10 and CXCR3 in the trigeminal ganglion contribute to trigeminal neuropathic pain in mice

YY Ju, M Jiang, F Xu, D Wang, B Ding… - Journal of Pain …, 2021 - Taylor & Francis
Purpose Trigeminal neuropathic pain is very common clinically, but effective treatments are
lacking. Chemokines and their receptors have been implicated in the pathogenesis of …

[HTML][HTML] Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain

ZJ Zhang, YL Dong, Y Lu, S Cao, ZQ Zhao… - Journal of …, 2012 - Springer
Background Neuropathic pain in the trigeminal system is frequently observed in clinic, but
the mechanisms involved are largely unknown. In addition, the function of immune cells and …

[HTML][HTML] Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice

Q Zhang, DL Cao, ZJ Zhang, BC Jiang… - Journal of …, 2016 - Springer
Background Trigeminal nerve damage-induced neuropathic pain is a severely debilitating
chronic orofacial pain syndrome. Spinal chemokine CXCL13 and its receptor CXCR5 were …

Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain

X Luo, WL Tai, L Sun, Z Pan, Z Xia, SK Chung… - Molecular …, 2016 - journals.sagepub.com
Background Chemokine axis chemokine CXC motif ligand 12/CXC chemokine receptor type
4 (CXCL12/CXCR4) is an emerging pain modulator, but mechanisms for its involvement in …

Chemokine CXCL13 activates p38 MAPK in the trigeminal ganglion after infraorbital nerve injury

Q Zhang, MD Zhu, DL Cao, XQ Bai, YJ Gao, XB Wu - Inflammation, 2017 - Springer
Recent data demonstrated that chemokine CXCL13 mediates neuroinflammation and
contributes to the maintenance of neuropathic pain after nerve injury in the spinal cord. Pro …

Chemokine ligand 2/chemokine receptor 2 signaling in the trigeminal ganglia contributes to inflammatory hyperalgesia in rats

M Takeda, M Nasu, T Kanazawa, M Takahashi… - Neuroscience …, 2018 - Elsevier
This study investigated the functional significance of hyperalgesia in the CCL2/CCR2
signaling system in trigeminal ganglion (TG) neurons following inflammation. Inflammation …

Neuronal-derived Ccl7 drives neuropathic pain by promoting astrocyte proliferation

BC Ke, XX Huang, Y Li, LY Li, QX Xu, Y Gao, Y Liu… - …, 2016 - journals.lww.com
Recent studies suggest that peripheral nerve injury converts resting spinal cord astroglial
cells into an activated state, which is required for the development and maintenance of …

Chemokine (CC motif) receptor 5 is an important pathological regulator in the development and maintenance of neuropathic pain

K Matsushita, H Tozaki-Saitoh, C Kojima… - …, 2014 - pubs.asahq.org
Background: The chemokine family has been revealed to be involved in the pathogenesis of
neuropathic pain. In this study, the authors investigated the role of chemokine (CC motif) …

[HTML][HTML] CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5

BC Jiang, DL Cao, X Zhang, ZJ Zhang… - The Journal of …, 2016 - Am Soc Clin Investig
Recent studies have implicated chemokines in microglial activation and pathogenesis of
neuropathic pain. CXC motif chemokine 13 (CXCL13) is a B lymphocyte chemoattractant …